These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine]. Ostrovskaia RU; Liapina LA; Pastorova VE; Mirzoev TKh; Gudasheva TA; Seredenin SB; Ashmarin IP Eksp Klin Farmakol; 2002; 65(2):34-7. PubMed ID: 12109290 [TBL] [Abstract][Full Text] [Related]
6. [Identification in the rat brain of cyclo-prolylglycine, a novel endogenous peptide with nootropic activity]. Gudasheva TA; Boĭko SS; Akparov VKh; Ostrovskaia RU; Rozantsev GG; Voronina TA; Zherdev VP; Seredenin SB Dokl Akad Nauk; 1996 Oct; 350(6):834-6. PubMed ID: 8998456 [No Abstract] [Full Text] [Related]
7. [The use of the HPLC method for the quantitative determination of a peptide analog of piracetam with nootropic activity and its main metabolites]. Boĭko SS; Zherdev VP; Gudasheva TA; Vasilevich NI; Ostrovskaia RU; Voronina TA; Rozantsev GG Eksp Klin Farmakol; 1996; 59(2):38-40. PubMed ID: 8974563 [TBL] [Abstract][Full Text] [Related]
8. [Dipeptide nootropic agent GVS-111 prevents accumulation of the lipid peroxidation products during immobilization]. Lysenko AV; Uskova NI; Ostrovskaia RU; Gudasheva TA; Voronina TA Eksp Klin Farmakol; 1997; 60(5):15-8. PubMed ID: 9483398 [TBL] [Abstract][Full Text] [Related]
9. [Design of the novel dipeptide neuropsychotropic drug preparations]. Gudasheva TA; Skoldinov AP Eksp Klin Farmakol; 2003; 66(2):15-9. PubMed ID: 12962042 [TBL] [Abstract][Full Text] [Related]
10. Neuroprotective properties of nootropic dipeptide GVS-111 in in vitro oxygen-glucose deprivation, glutamate toxicity and oxidative stress. Andreeva NA; Stel'mashuk EV; Isaev NK; Ostrovskaya RU; Gudasheva TA; Viktorov IV Bull Exp Biol Med; 2000 Oct; 130(10):969-72. PubMed ID: 11177296 [TBL] [Abstract][Full Text] [Related]
11. The effects of piracetam and its novel peptide analogue GVS-111 on neuronal voltage-gated calcium and potassium channels. Solntseva EI; Bukanova JV; Ostrovskaya RU; Gudasheva TA; Voronina TA; Skrebitsky VG Gen Pharmacol; 1997 Jul; 29(1):85-9. PubMed ID: 9195198 [TBL] [Abstract][Full Text] [Related]
12. Cyclopropyl glycine and proline-containing preparation noopept evoke two types of membrane potential responses in synaptoneurosomes. Lutsenko VK; Vukolova MN; Gudasheva TA Bull Exp Biol Med; 2003 Jun; 135(6):559-62. PubMed ID: 12937673 [TBL] [Abstract][Full Text] [Related]
13. [The effect of the new nootropic dipeptide GVS-111 in different functional disorders of the escape reaction]. Inozemtsev AN; Trofimov SS; Borlikova GG; Firova FA; Pragina LL; Gudasheva TA; Ostrovskaia RU; Tushmalova NA; Voronina TA Eksp Klin Farmakol; 1998; 61(3):10-2. PubMed ID: 9690067 [TBL] [Abstract][Full Text] [Related]
17. Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model. Ostrovskaya RU; Romanova GA; Barskov IV; Shanina EV; Gudasheva TA; Victorov IV; Voronina TA; Seredenin SB Behav Pharmacol; 1999 Sep; 10(5):549-53. PubMed ID: 10780261 [TBL] [Abstract][Full Text] [Related]
18. [The role of non-NMDA glutamate receptors in the EEG effects of chronic administration of noopept GVS-111 in awake rats]. Kovalev GI; Vorob'ev VV Eksp Klin Farmakol; 2002; 65(6):6-9. PubMed ID: 12596524 [TBL] [Abstract][Full Text] [Related]
19. [Role of functional state of neuronal mitochondria of cerebral cortex in mechanisms of nootropic activity of neuroprotectors in rats with alloxan hyperglycemia]. Zhiliuk VI; Mamchur VI; Pavlov SV Eksp Klin Farmakol; 2015; 78(2):10-4. PubMed ID: 25898541 [TBL] [Abstract][Full Text] [Related]